Rod and Cone Dystrophy is a progressive, inherited retinal condition, and as with most genetic retinal disorders, conventional treatment remains focused on low-vision aids, UV protection, and monitoring disease progression rather than reversal. India has become a preferred destination for **Rod and Cone Dystrophy treatment for patients from Pakistan**, though it remains important to note that a definitive cure for this genetic condition is still a complex and ongoing pursuit within the medical field.
As part of a broader rod and cone dystrophy treatment approach, stem cell-based therapy is regarded as an area of active interest for patients whose photoreceptor cells are progressively degenerating. This treatment avenue is explored for its potential to support the surviving rod and cone cell population, offering patients an additional option to discuss with their care team alongside standard low-vision management
Within a structured rod and cone dystrophy treatment protocol, Mesenchymal stem cell injections delivered through the Retro-bulbar route have proven to be a reliable option, typically requiring one or two sessions. This method has shown a favorable history in supporting the regenerative response of retinal cells affected by progressive photoreceptor loss, with relevance extending to photoreceptor cells, retinal pigment epithelium, and macular cells.
Patients from Pakistan managing this inherited condition are encouraged to connect with the Eye Stem Cell Center, which brings more than 12 years of focused experience with genetic retinal dystrophies. Our team conducts a thorough, report-based review — including ERG and OCT findings — before advising on next steps.
Eye Stem Cell Center is one of the most trusted providers of Rod and Cone Dystrophy treatment in Pakistan.

